56 related articles for article (PubMed ID: 16685197)
1. Interpreting antioxidant responses to angiotensin AT1 receptor antagonists: pharmacology or chemistry?
Ford WR
J Hypertens; 2006 Jun; 24(6):1013-6. PubMed ID: 16685197
[No Abstract] [Full Text] [Related]
2. Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species.
Jaimes EA; Zhou MS; Pearse DD; Puzis L; Raij L
Am J Physiol Renal Physiol; 2008 Feb; 294(2):F385-92. PubMed ID: 18094033
[TBL] [Abstract][Full Text] [Related]
3. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension.
Yu Y; Fukuda N; Yao EH; Matsumoto T; Kobayashi N; Suzuki R; Tahira Y; Ueno T; Matsumoto K
Am J Hypertens; 2008 Jan; 21(1):72-7. PubMed ID: 18091747
[TBL] [Abstract][Full Text] [Related]
4. Effects of tempol and candesartan on neural control of the kidney.
Eppel GA; Head GA; Denton KM; Evans RG
Auton Neurosci; 2012 May; 168(1-2):48-57. PubMed ID: 22336580
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II induces human astrocyte senescence through reactive oxygen species production.
Liu G; Hosomi N; Hitomi H; Pelisch N; Fu H; Masugata H; Murao K; Ueno M; Matsumoto M; Nishiyama A
Hypertens Res; 2011 Apr; 34(4):479-83. PubMed ID: 21270817
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.
Wang JL; Zhang J; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
Eur J Med Chem; 2012 Mar; 49():183-90. PubMed ID: 22309912
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor.
Fukuda K; Hirooka K; Mizote M; Nakamura T; Itano T; Shiraga F
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3629-38. PubMed ID: 20164447
[TBL] [Abstract][Full Text] [Related]
8. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
[TBL] [Abstract][Full Text] [Related]
9. Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation.
Grote K; Ortmann M; Salguero G; Doerries C; Landmesser U; Luchtefeld M; Brandes RP; Gwinner W; Tschernig T; Brabant EG; Klos A; Schaefer A; Drexler H; Schieffer B
Cardiovasc Res; 2006 Aug; 71(3):596-605. PubMed ID: 16843452
[TBL] [Abstract][Full Text] [Related]
10. Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension.
Parrish MR; Wallace K; Tam Tam KB; Herse F; Weimer A; Wenzel K; Wallukat G; Ray LF; Arany M; Cockrell K; Martin JN; Dechend R; LaMarca B
Am J Hypertens; 2011 Jul; 24(7):835-40. PubMed ID: 21472019
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
Whaley-Connell A; Govindarajan G; Habibi J; Hayden MR; Cooper SA; Wei Y; Ma L; Qazi M; Link D; Karuparthi PR; Stump C; Ferrario C; Sowers JR
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E355-63. PubMed ID: 17440033
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of losartan and candesartan on vasoconstrictor responses in the rat.
Nossaman BD; Baber SR; Nazim MM; Detrolio JD; Kadowitz PJ
Can J Physiol Pharmacol; 2007; 85(3-4):360-71. PubMed ID: 17612645
[TBL] [Abstract][Full Text] [Related]
13. Different protective actions of losartan and tempol on the renal inflammatory response to acute sodium overload.
Rosón MI; Della Penna SL; Cao G; Gorzalczany S; Pandolfo M; Toblli JE; Fernández BE
J Cell Physiol; 2010 Jul; 224(1):41-8. PubMed ID: 20232302
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT₁ receptor antagonists.
Zhang J; Wang JL; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
Bioorg Med Chem; 2012 Jul; 20(14):4208-16. PubMed ID: 22727371
[TBL] [Abstract][Full Text] [Related]
15. Role of AT1 receptors in permeability of the blood-brain barrier in diabetic hypertensive rats.
Awad AS
Vascul Pharmacol; 2006 Sep; 45(3):141-7. PubMed ID: 16959546
[TBL] [Abstract][Full Text] [Related]
16. Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan.
Iwai M; Li HS; Chen R; Shiuchi T; Wu L; Min LJ; Li JM; Tsuda M; Suzuki J; Tomono Y; Tomochika H; Mogi M; Horiuchi M
J Pharmacol Exp Ther; 2006 Dec; 319(3):1081-7. PubMed ID: 16990512
[TBL] [Abstract][Full Text] [Related]
17. Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonists.
Berellini G; Cruciani G; Mannhold R
J Med Chem; 2005 Jun; 48(13):4389-99. PubMed ID: 15974591
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma.
Yang H; Hirooka K; Fukuda K; Shiraga F
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5800-4. PubMed ID: 19608537
[TBL] [Abstract][Full Text] [Related]
19. Activation of AP-1 through reactive oxygen species by angiotensin II in rat cardiomyocytes.
Wu S; Gao J; Ohlemeyer C; Roos D; Niessen H; Köttgen E; Gessner R
Free Radic Biol Med; 2005 Dec; 39(12):1601-10. PubMed ID: 16298685
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin type-1 receptor blocker candesartan inhibits calcium oxalate crystal deposition in ethylene glycol-treated rat kidneys.
Yoshioka I; Tsujihata M; Akanae W; Nonomura N; Okuyama A
Urology; 2011 Apr; 77(4):1007.e9-1007.e14. PubMed ID: 21256551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]